Zennova Pharmaceutical's American original technology platform, 20 years of continuous development, based on the substance thermodynamics phase balance theory, substance diffusion theory, and pulsed microdialysis principle (PMD), has solved the monitoring industry problems of substance distribution and migration in the micro environment. It is the only in vitro biological consistency assessment technology approved by FDA for complex heterogeneous preparations. It is a global leader in the future, We look forward to collaborating with more domestic and foreign companies and teams to jointly discover and research innovative drugs that improve patient life. If you have any cooperation intentions, please contact us: info@zennova.com